The latest announcement is out from Intelligent Bio Solutions ( (INBS) ).
Intelligent Bio Solutions Inc. recently rewarded its top executives with a significant stock award, as part of their 2024 compensation strategy. CEO Harry Simeonidis received 40,000 shares, and CFO Spiro Sakiris was granted 34,500 shares, both fully vested. With the stock priced at $76,400 for Simeonidis and $65,895 for Sakiris on the day of the award, these grants underline the company’s commitment to aligning executive interests with shareholder value.
For an in-depth examination of INBS stock, go to TipRanks’ Stock Analysis page.
